BRCA1: What Do We Know? What Do We Think We Know? What Do We Really Need to Know?

By Buller R.E.  

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 291-293

Elsevier

Access to resources Recommend Favorite

Chemotherapy in alveolar soft part sarcomas - What do we know?

By Reichardt P.   Lindner T.   Pink D.   Thuss-Patience P.C.   Kretzschmar A.   Dorken B.  

European Journal of Cancer, Vol. 39, Iss. 11, 2003-07 ,pp. : 1511-1516

Elsevier

Access to resources Recommend Favorite

Treatment of performance status 2 patients with advanced non-small-cell lung cancer: what we know and what we don’’t know

By Tartarone Alfredo   Aieta Michele  

Future Oncology, Vol. 5, Iss. 6, 2009-08 ,pp. : 837-841

Future Medicine

Access to resources Recommend Favorite

Management of Testicular Germ Cell Tumors

By Robert A. Huddart   David P. Dearnaley   Alan Horwich  

American Journal of Cancer, Vol. 2, Iss. 5, 2003-01 ,pp. : 325-334

Adis International

Access to resources Recommend Favorite

What have we learnt from previous phase II trials to help in the management of childhood brain tumours?

By Chastagner P.   Bouffet E.   Grill J.   Kalifa C.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 1981-1993

Elsevier

Access to resources Recommend Favorite